The history of Viagra and its effect on the pharmaceutical sector presents a complex question regarding its continued viability as an investment. Initially a remarkable success, generating vast revenues, generic competition has considerably eroded profit margins . While established pharmaceutical firms continue patents on related therapies and expl

The outlook of companies tied to iconic drugs like Viagra presents a complex investment picture. While the initial rise of copyright, fueled by Viagra's extraordinary popularity, generated substantial wealth , the loss of exclusivity in key regions has introduced significant uncertainty . Investors are now facing the effect of generic competition ,